Gsa Capital Partners LLP Ptc Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 30,982 shares of PTCT stock, worth $2.12 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
30,982Holding current value
$2.12 Million% of portfolio
0.11%Shares
15 transactions
Others Institutions Holding PTCT
# of Institutions
309Shares Held
79.4MCall Options Held
255KPut Options Held
151K-
Vanguard Group Inc Valley Forge, PA8.85MShares$605 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$531 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$530 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$324 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$321 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.89B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...